C. elegans is able to modulate the expression of chemoreceptors in response to neuronal activity and environmental cues. This provides a simple mechanism by which C. elegans can rapidly alter its sensory behaviors in response to changing conditions. How is the expression of chemoreceptor genes regulated? Previously, we showed that the Ser/Thr-kinase KIN-29 regulates the efficient expression of a subset of chemoreceptors.
kin-29 mutants exhibit reduced expression of
str-1 and
sra-6 in the AWB olfactory and ASH sensory neurons, respectively. In addition,
kin-29 mutants exhibit a reduced body-size and are hypersensitive to dauer pheromone, indicative of alterations in the ability to correctly sense environmental conditions. All phenotypes can be rescued by
kin-29 expression in chemosensory neurons, suggesting that modulation of receptor expression may be crucial for regulating body-size and pheromone responses. However, the mechanisms through which KIN-29 functions to regulate chemoreceptor gene expression are unknown. In order to identify targets of KIN-29, we identified suppressor mutations in the MADS-box transcription factor
mef-2 and the class II histone deacetylase
hda-4. MEF2 and class II HDACs have previously been shown to regulate gene expression in response to intracellular signaling and electrical activity in neurons. Cell-specific expression indicates that
mef-2 and
hda-4 function in chemosensory neurons to regulate the KIN-29-mediated phenotypes. To further investigate MEF-2/HDA-4 function, we dissected the cis-regulatory sequences driving
str-1 expression. We compared promoter sequences of
str-1 and its ortholog in C. briggsae and carried out promoter deletion analyses. We found that sequences required for developmentally regulated
str-1 expression in AWB are distinct from sequences required for KIN-29-mediated modulation of expression levels. Within the sequences required for conferring KIN-29-mediated regulation, we identified a putative MEF-2 binding site. Interestingly, loss of either this MEF-2 site but also a conserved GATA factor binding site resulted in alteration of
str-1 expression, suggesting that KIN-29 may function through a MEF-2/GATA/HDA-4 complex to modulate expression. We have identified these sites upstream of a subset of chemoreceptor genes and are determining whether they are also regulated by KIN-29. Finally, preliminary results suggest that neuronal activity may play a role in regulating the KIN-29-mediated modulation of
str-1 expression. Taken together, our findings suggest a role for chromatin remodeling in the regulation of chemoreceptor gene expression, and reveal an unexpected complexity in the mechanisms required for correct receptor expression levels.